Vontobel Holding’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Vontobel Holding's BMY Position: Q1 2026 in Review
Vontobel Holding reduced its Bristol-Myers Squibb (BMY) stake by 8.8% in Q1 2026, selling an estimated $3.92M and leaving 695,820 shares worth $42.2M. The position accounts for 0.15% of the portfolio, ranked #136.
Vontobel Holding first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $132M in Q4 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Vontobel Holding held 695,820 shares of Bristol-Myers Squibb worth $42.2M as of Q1 2026.
- Vontobel Holding sold 67,308 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.92M.
- Bristol-Myers Squibb made up 0.15% of Vontobel Holding's portfolio in Q1 2026, its #136 holding.
- Vontobel Holding first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
- Vontobel Holding's Bristol-Myers Squibb position peaked at $132M in Q4 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.